北京大學(xué)腫瘤醫(yī)院(北京腫瘤醫(yī)院、北京大學(xué)臨床腫瘤學(xué)院、北京市腫瘤防治研究所)始建于1976年，是一所由北京大學(xué)、北京市醫(yī)院管理中心共管的三級(jí)甲等腫瘤專(zhuān)科醫(yī)院。
北京大學(xué)腫瘤醫(yī)院設(shè)有35個(gè)臨床科室，14個(gè)醫(yī)技科室，10個(gè)基礎(chǔ)研究科室,4個(gè)基礎(chǔ)平臺(tái)科室,開(kāi)放床位801張。全年門(mén)診量75萬(wàn)人次，年收治病人9.6萬(wàn)人次，手術(shù)1.7萬(wàn)例。醫(yī)院職工近2600人，在編職工中正高級(jí)職稱(chēng)152人，副高級(jí)職稱(chēng)253人。
北京大學(xué)腫瘤醫(yī)院有國(guó)家重點(diǎn)學(xué)科1個(gè)(腫瘤學(xué))、國(guó)家臨床重點(diǎn)專(zhuān)科2個(gè)(腫瘤科、病理科)、北京市重點(diǎn)學(xué)科4個(gè)(胃癌防治中心、乳腺癌防治中心、影像介入治療中心、超聲診斷中心)、北京市中醫(yī)管理局重點(diǎn)學(xué)科1個(gè)(中西醫(yī)結(jié)合科暨老年腫瘤科)，全國(guó)名老中醫(yī)藥專(zhuān)家傳承工作室1個(gè)，北京學(xué)者工作室2個(gè)，是惡性腫瘤發(fā)病機(jī)制及轉(zhuǎn)化研究教育部重點(diǎn)實(shí)驗(yàn)室、惡性腫瘤轉(zhuǎn)化研究北京市重點(diǎn)實(shí)驗(yàn)室、國(guó)家藥監(jiān)局重點(diǎn)實(shí)驗(yàn)室所在單位、抗腫瘤新藥及新技術(shù)研發(fā)北京市工程研究中心、北京市國(guó)際科技合作基地、北京市首批示范性研究型病房、科技部抗腫瘤新藥療效與安全性評(píng)價(jià)信息化平臺(tái)的建設(shè)單位。被國(guó)家衛(wèi)健委授予首批腫瘤多學(xué)科診療試點(diǎn)醫(yī)院、國(guó)家首批腫瘤高通量基因測(cè)序臨床試點(diǎn)單位;是唯一承擔(dān)北京地區(qū)癌癥發(fā)病登記與生存統(tǒng)計(jì)，并向政府及WHO提供數(shù)據(jù)的中心。是北京抗癌協(xié)會(huì)、北京癌癥康復(fù)會(huì)的掛靠和依托單位。
北京大學(xué)腫瘤醫(yī)院現(xiàn)有工程院院士1名、長(zhǎng)江學(xué)者獎(jiǎng)勵(lì)計(jì)劃特聘教授2名，自建院以來(lái)先后有4人獲國(guó)家自然科學(xué)基金杰出青年、11人獲突出貢獻(xiàn)專(zhuān)家，42人獲政府特殊津貼。現(xiàn)有教授43名、副教授81名、博士研究生導(dǎo)師59名、碩士研究生導(dǎo)師69名。
醫(yī)院自成立以來(lái)，致力于胃癌、乳腺癌、肺癌、結(jié)直腸癌、肝癌、食管癌、惡性淋巴瘤、惡性黑色素瘤、泌尿系統(tǒng)腫瘤、婦科腫瘤、頭頸部腫瘤、骨腫瘤、軟組織與腹膜后腫瘤等各種腫瘤的診斷、綜合治療和轉(zhuǎn)化研究。其中胃癌防治體系方面的研究?jī)纱潍@得了國(guó)家科技進(jìn)步二等獎(jiǎng)。
研究所建所以來(lái)，在腫瘤學(xué)基礎(chǔ)理論研究、常見(jiàn)主要腫瘤的臨床診斷與治療、胃癌、食管癌高發(fā)區(qū)現(xiàn)場(chǎng)的預(yù)防干預(yù)研究等領(lǐng)域均有創(chuàng)新與領(lǐng)先的成績(jī)，在國(guó)內(nèi)外頗具影響。
北京大學(xué)腫瘤醫(yī)院是全國(guó)腫瘤學(xué)博士學(xué)位授權(quán)點(diǎn)和博士后流動(dòng)站。醫(yī)學(xué)教育涵蓋本科生、碩士生、博士生、博士后以及進(jìn)修生、職工的繼續(xù)教育。每年定期舉辦全國(guó)臨床腫瘤醫(yī)師進(jìn)修班和國(guó)家繼續(xù)教育項(xiàng)目全國(guó)性學(xué)習(xí)班。
北京大學(xué)腫瘤醫(yī)院與許多國(guó)際知名腫瘤研究機(jī)構(gòu)建立了密切的合作關(guān)系，每年不斷有國(guó)內(nèi)外專(zhuān)家學(xué)者來(lái)院參觀、考察、講學(xué)，進(jìn)行科研協(xié)作與學(xué)術(shù)交流。醫(yī)院也不斷有科研、臨床、醫(yī)技專(zhuān)業(yè)人員出國(guó)訪問(wèn)、進(jìn)修、短期工作或參加國(guó)際學(xué)術(shù)會(huì)議。
北京大學(xué)腫瘤醫(yī)院以建設(shè)患者首選的國(guó)際化腫瘤集團(tuán)中心為自己的發(fā)展愿景，堅(jiān)持內(nèi)生式發(fā)展、外延式增長(zhǎng)兩個(gè)發(fā)展方向，實(shí)施國(guó)內(nèi)前列、國(guó)內(nèi)頂尖、國(guó)際知名三個(gè)發(fā)展階段，采取過(guò)硬的品牌學(xué)科、優(yōu)秀的管理團(tuán)隊(duì)、頂級(jí)的專(zhuān)家隊(duì)伍、人性化的醫(yī)院文化思想四項(xiàng)發(fā)展措施，讓每一位腫瘤患者在就醫(yī)中獲益。
地址：中國(guó)北京市海淀區(qū)阜成路52號(hào)
聯(lián)系電話(huà)：0086-10-8812 1122
傳真：0086-10-8812 2437
郵編：100142
網(wǎng)址：http://www.bjcancer.org
Peking University Cancer Hospital
Peking University Cancer Hospital (also referred to as Beijing Cancer Hospital, Peking University School of Oncology, and Beijing Institute for Cancer Research) was founded in 1976 and is co-administered by Peking University and Beijing Hospitals Authority. It is a tertiary A-level hospital specializing in cancer treatment, research, prevention, and medical education.
The hospital has 35 clinical departments,14 medical technology departments, and 10 basic research laboratories. Its current number of beds is 801. It receives around 750,000 outpatient visits, with 96,000 inpatients admitted and 17,000 operations performed annually. The hospital has nearly 2,600 employees, including 152 with professor-level titles and 253 with associate-professor-level titles.
Peking University Cancer Hospital has one National Key Academic Discipline (oncology), two National Key Clinical Specialties (oncology and pathology), four Beijing Municipal Key Academic Disciplines (gastric oncology, breast oncology, interventional radiology, and sonography), and one Beijing Administration of Traditional Chinese Medicine Key Academic Discipline (integrated medicine and geriatric oncology). It is also home to one National Distinguished Traditional Chinese Medicine Practitioner’s Heritage Office, and two Beijing Scholar’s Offices. It has been designated as the Key Laboratory of Carcinogenesis and Translational Research by the Ministry of Education of the P. R. China and the Beijing Municipal Science & Technology Commission, National Medical Products Administration Key Laboratory, Beijing Engineering Research Center for New Anti-Tumor Drug and Technology Research and Development, Beijing International Science and Technology Cooperation Base, Beijing Exemplary Research Ward (first batch), and one of the builders of the information platform for the efficacy and safety evaluation of new anti-tumor drugs of the Ministry of Science and Technology. It is among the first hospitals participating in the National Health Commission’s pilot programs on multidisciplinary diagnosis and treatment of cancer and clinical application of tumor high-throughput gene sequencing. It is the only cancer registry center for Beijing, tracking cancer incidence and survival in the capital and providing data to the government and WHO. Beijing Anti-Cancer Association and Beijing Cancer Rehabilitation Society are also supported by the hospital.
Peking University Cancer Hospital has one member of the Chinese Academy of Engineering, two Changjiang Scholars Program Distinguished Professors, four winners of the National Science Fund for Distinguished Young Scholars, 11 National Young and Middle-aged Experts with Outstanding Contributions, and 42 winners of the Special Government Allowances of the State Council. Of its employees, 43 are professors, 81 associate professors, 59 doctoral supervisors and 69 master supervisors.
Since its establishment, the hospital has been dedicated to diagnosis, comprehensive treatment and translational research regarding gastric cancer, breast cancer, lung cancer, colorectal cancer, liver cancer, esophageal cancer, malignant lymphoma, malignant melanoma, urinary system tumors, gynecological tumors, head and neck tumors, bone tumors, sarcomas, etc. Its research on gastric cancer prevention and treatment system has won the second prize of National Science and Technology Progress Award twice.
The research labs have made innovative and leading achievements in the fields of basic theoretical research in oncology, diagnosis and treatment of common tumors, and preventive intervention research in high-incidence areas of gastric and esophageal cancer, which have considerable influence on the oncology landscape both at home and abroad.
Peking University Cancer Hospital is a national doctoral degree conferring unit and a postdoctoral research mobile station in the discipline of oncology. It offers medical education for undergraduates, graduate programs (master’s and doctoral level), postdoctoral research opportunities and continuing education for employees and visitors. The hospital holds the National Clinical Oncologist Advanced Course and the National Medical Continuing Education Program Nationwide Training on a yearly basis.
The hospital has established close cooperative relations with many world-renown cancer institutions. Each year, prestigious experts and scholars come to the hospital to visit, conduct academic exchange, and carry out research collaboration. And its researchers, doctors, nurses, and medical technologists also goes abroad for advanced training, joint research, and international academic conferences.
With the vision of building up an international cancer care group among the patient’s first choices, Peking University Cancer Hospital attaches great importance to both improving quality and efficiency of care and expanding spectrum of services, and strives to establish its flagship oncological subdisciplines, an excellent management team, a group of top-notch experts and a people-centered hospital culture for the sole purpose of providing safe and quality care to each of our patients.
Address: 52 Fucheng Rd., Haidian District, Beijing 100142, China
Phone: 0086-10-8812 1122
Fax: 0086-10-8812 2437
Website: http://www.bjcancer.org
